First of all, there’s the largest survey in women with endometrial cancer and we know we have an evolving landscape and we talk about patient reported outcomes, we talk about quality of life, but it’s really a little bit shameful that we have so few data asking patients directly. The first result is a huge interest of women with endometrial cancer to fulfill such questionnaires...
First of all, there’s the largest survey in women with endometrial cancer and we know we have an evolving landscape and we talk about patient reported outcomes, we talk about quality of life, but it’s really a little bit shameful that we have so few data asking patients directly. The first result is a huge interest of women with endometrial cancer to fulfill such questionnaires. And what we can see is that patients are not well informed about the innovations we have, what it means in the molecular diagnostics. But even in the health literacy, I think there is huge space to improve in education, information. What the patient stated even that there are still very few materials. And what we also have seen that they are missing structures where the different doctors, the different disciplines talk to each other, especially in the cancer care follow-up. Because we know that women with endometrial cancer have frequently other comorbidities, such as hypertension, diabetes, what also influence the cancer survival, but even they are at risk to suffer from heart attack for instance. But in the cancer care follow-up program, these structures are missing. So this is one of the results we presented here as a poster. Thank you.
This transcript is AI-generated. While we strive for accuracy, please verify this copy with the video.
